Should You Take Blood Pressure Medication When Starting TRT? (TRT Q&As)
Timeline
Dr. O’Connor says 117/77 is excellent blood pressure and cautions against unnecessarily lowering it or the heart rate with Bystolic. He recommends monitoring the ABCDs as TRT begins and choosing any blood pressure treatment according to the individual’s health history.
Dr. O’Connor points to the combination of enclomiphene and 200 mg of testosterone per week as a potential contributor even with a normal estrogen result. He considers the testosterone dose excessive and recommends addressing the regimen rather than automatically treating the estrogen number.
Dr. O’Connor is particularly concerned because the man has already suffered a stroke. Despite feeling strong and having good libido, he urges him to back off the additional steroids, remain on appropriate TRT, and closely monitor his health through the ABCDs.
Dr. O’Connor describes Proviron as a relatively mild androgen but stresses that long-term use still requires attention to the prostate, lipids, and overall health. For a 57-year-old considering adding it to TRT, he emphasizes ongoing ABCDs and prostate screening.
Dr. O’Connor says seven days is far too soon to judge recovery after steroid use and PCT, even when testosterone looks good on paper. Sexual and hormonal recovery can take months, and he cautions a 28-year-old against immediately jumping onto lifelong TRT.
Dr. O’Connor confirms that using testosterone and Primobolan will suppress natural testosterone production. He urges the young man to carefully consider whether the potential consequences are worth it before choosing to use anabolic steroids at such a young age.
Video Summary
This mailbag discussion focuses on questions about reassessing goals during testosterone therapy when progress feels uncertain. It explains that goals may need refinement as symptoms, labs, and expectations evolve over time. Reassessment is framed as part of responsible long-term care rather than a setback.
A central portion discusses how labs, symptom patterns, and overall wellbeing should be reviewed together when goals feel unclear. The episode emphasizes avoiding reactive changes in favor of structured evaluation. Contextual interpretation is highlighted to guide next steps.
The closing segment reinforces testosterone therapy as adaptive, longitudinal care. Ongoing monitoring, expectation alignment, and proportional decisions are emphasized. Hormone therapy is positioned as benefiting from periodic reassessment.
Drug Callouts
Condition Callouts
Key Takeaways
- Reassessing goals is part of long-term therapy.
- Unclear progress does not imply failure.
- Labs and symptoms guide refinement.
- Structured evaluation improves clarity.
- Adaptation supports sustained outcomes.